An Advanced

Drug Development Company

Golden Biotechnology Corporation (GBC) is an Advanced Drug Development Company with an established Team that have a proven track record in Clinical Development, Regulatory Affairs & Commercialization.

GBC is focused on the clinical development of new therapeutic agents that can meet the needs of patients with of High Unmet Medical Needs.

Antroquinonol is an innovative compound discovered by the GBC Team with excellent Efficacy and Safety Profile. Antroquinonol have completed a number of Phase 1 and 2 studies in difficult to treat indications – Oncology and Infectious Diseases.

GBC’s looks excitedly to the future to solve the hardest questions on Antroquinonol to ultimately benefit patients and healthcare professionals.